Equities analysts expect PetMed Express, Inc. (NASDAQ:PETS) to announce earnings of $0.35 per share for the current quarter, according to Zacks. Three analysts have made estimates for PetMed Express’ earnings, with the highest EPS estimate coming in at $0.41 and the lowest estimate coming in at $0.30. PetMed Express posted earnings of $0.24 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 45.8%. The business is scheduled to report its next quarterly earnings report on Monday, January 22nd.

On average, analysts expect that PetMed Express will report full year earnings of $1.66 per share for the current financial year, with EPS estimates ranging from $1.57 to $1.76. For the next fiscal year, analysts expect that the firm will post earnings of $1.67 per share, with EPS estimates ranging from $1.61 to $1.73. Zacks’ earnings per share averages are an average based on a survey of analysts that that provide coverage for PetMed Express.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.13. The business had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $63.41 million. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.24 EPS.

PETS has been the subject of a number of recent research reports. Sidoti upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 target price for the company in a research note on Thursday, August 24th. BidaskClub lowered PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Zacks Investment Research lowered PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. Northcoast Research upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 target price for the company in a research note on Monday, July 24th. Finally, Craig Hallum lowered PetMed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. PetMed Express currently has an average rating of “Hold” and an average target price of $42.00.

PetMed Express (NASDAQ:PETS) opened at 35.36 on Wednesday. The stock has a 50 day moving average price of $35.80 and a 200 day moving average price of $36.83. PetMed Express has a 52 week low of $18.90 and a 52 week high of $50.90. The stock has a market cap of $717.53 million, a PE ratio of 27.20 and a beta of 1.03.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 17th. Shareholders of record on Monday, November 6th will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, November 3rd. This represents a $0.80 dividend on an annualized basis and a yield of 2.26%. PetMed Express’s dividend payout ratio (DPR) is presently 53.69%.

In other PetMed Express news, Director Ronald J. Korn sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $35.57, for a total transaction of $35,570.00. Following the completion of the sale, the director now owns 73,833 shares in the company, valued at approximately $2,626,239.81. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 4.00% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of PETS. Ameriprise Financial Inc. grew its stake in PetMed Express by 6.1% during the 1st quarter. Ameriprise Financial Inc. now owns 159,220 shares of the company’s stock valued at $3,183,000 after purchasing an additional 9,164 shares in the last quarter. Arizona State Retirement System grew its stake in PetMed Express by 0.9% during the 1st quarter. Arizona State Retirement System now owns 10,667 shares of the company’s stock valued at $215,000 after purchasing an additional 100 shares in the last quarter. Principal Financial Group Inc. grew its stake in PetMed Express by 3.4% during the 1st quarter. Principal Financial Group Inc. now owns 166,478 shares of the company’s stock valued at $3,353,000 after purchasing an additional 5,478 shares in the last quarter. Teachers Advisors LLC grew its stake in PetMed Express by 1.8% during the 1st quarter. Teachers Advisors LLC now owns 61,884 shares of the company’s stock valued at $1,246,000 after purchasing an additional 1,097 shares in the last quarter. Finally, Thrivent Financial For Lutherans grew its stake in PetMed Express by 4.1% during the 1st quarter. Thrivent Financial For Lutherans now owns 11,530 shares of the company’s stock valued at $232,000 after purchasing an additional 450 shares in the last quarter. Hedge funds and other institutional investors own 81.08% of the company’s stock.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/01/petmed-express-inc-pets-expected-to-announce-earnings-of-0-35-per-share.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Get a free copy of the Zacks research report on PetMed Express (PETS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.